N. Toledo Pons (Palma De Mallorca, Spain), O. Kurmi (Birmingham (West Midlands), United Kingdom), Y. Çolak (Herlev, Denmark)
Preserved Ratio Impaired Spirometry (PRISm) and mortality: the Rotterdam Study
S. Wijnant (Ghent, Belgium), E. De Roos (Ghent, Belgium), M. Kavousi (Rotterdam, Netherlands), B. Stricker (Rotterdam, Netherlands), N. Terzikhan (Rotterdam, Netherlands), L. Lahousse (Ghent, Belgium), G. Brusselle (Ghent, Belgium)
|  |
Residential greenness and lung function in a prospective cohort of European adults: The ECRHS study
I. Markevych (Munich, Germany), E. Fuertes (London, United Kingdom), A. Marcon (Verona, Italy), P. Dadvand (Barcelona, Spain), D. Nowak (Munich, Germany), J. Garcia Aymerich (Barcelona, Spain), D. Vienneau (Basel, Switzerland), K. De Hoogh (Basel, Switzerland), D. Jarvis (London, United Kingdom), M. Abramson (Melbourne, Australia), S. Accordini (Verona, Italy), A. Amaral (London, United Kingdom), H. Bentouhami (Antwerp, Belgium), R. Jacobsen Bertelsen (Bergen, Norway), A. Boudier (Grenoble, France), R. Bono (Turin, Italy), G. Bowatte (Kandy, Sri Lanka), A. Carsin (Barcelona, Spain), S. Dharmage (Melborne, Australia), B. Forsberg (Umeå, Sweden), T. Gislason (Reykjavik, Iceland), M. Gnesi (Pavia, Italy), M. Holm (Gothenburg, Sweden), B. Jacquemin (Versailles, France), C. Janson (Uppsala, Sweden), R. Jõgi (Tartu, Estonia), A. Johannessen (Bergen, Norway), D. Keidel (Basel, Switzerland), B. Leynaert (Villejuif, France), J. Maldonado Perez (Huelva, Spain), P. Marchetti (Verona, Italy), E. Migliore (Turin, Italy), J. Martínez Moratalla (Albacete, Spain), D. Olsson (Tartu, Estonia), H. Orru (Gothenburg, Sweden), I. Pin (Grenoble, France), J. Potts (London, United Kingdom), N. Probst-Hensch (Basel, Switzerland), A. Ranzi (Modena, Italy), J. Sánchez-Ramos (Huelva, Spain), V. Siroux (Grenoble, France), C. Schindler (Basel, Switzerland), D. Soussan (Paris, France), J. Sunyer (Barcelona, Spain), C. Svanes (Bergen, Norway), I. Urrutia Landa (Galdakao, Spain), S. Villani (Pavia, Italy), J. Weyler (Antwerp, Belgium), J. Heinrich (Munich, Germany)
|  |
Changes in smoking and lung function between 2001 and 2016. The Tromsø Study.
H. Melbye (Tromsø, Norway), A. Langhammer (Trondheim, Norway)
| |
Differences between men and women with COPD: The French Palomb Cohort
E. Ouaalaya (Bordeaux, France), L. Falque (Bordeaux, France), J. Dupis (Pessac, France), M. Sabatini (Bayonne, France), A. Bernady (Cambo les bains, France), L. Nguyen (Bordeaux, France), A. Ozier (Bordeaux, France), C. Nocent-Ejnaini (Bayonne, France), F. Le Guillou (la Rochelle, France), M. Molimard (Bordeaux, France), C. Raherison-Semjen (Bordeaux, France)
| |
Beta-blocker use and risk of acute exacerbations of COPD following first-time myocardial infarction. A Danish nationwide cohort study.
D. Rasmussen (Naestved, Denmark), U. Bodtger (Naestved, Denmark), M. Lamberts (Hellerup, Denmark), P. Lange (Copenhagen, Denmark), M. Jensen (Hellerup, Denmark)
| |
Impact of chronic cough in individuals with COPD: a population-based cohort study
M. Dahl (Køge, Denmark), E. Landt (Køge, Denmark), Y. Colak (Herlev, Denmark), P. Lange (Herlev, Denmark), L. Laursen (Herlev, Denmark), B. Nordestgaard (Herlev, Denmark)
| |
The association of anxiety and depression with mortality, symptom burden and health care utilization in a COPD cohort. The HUNT Study, Norway.
S. Vikjord (Levanger, Norway), X. Mai (Trondheim, Norway), B. Brumpton (Trondheim, Norway), A. Langhammer (Levanger, Norway)
| |
Hospital admissions in a 'real life' cohort of COPD patients in Spain.
M. Santibanez (Santander, Spain), R. Garrastazu (Santander, Spain), J. López-Caro (Santander, Spain), S. Arenal (Santander, Spain), J. Helguera (Santander, Spain), C. Bonnardeaux (Santander, Spain), C. Leon (Santander, Spain), L. Ruiz-Azcona (Santander, Spain), J. Garcia-Rivero (Santander, Spain)
| |
Elevated hsCRP is associated with respiratory symptoms in COPD
E. Lagrange (Umeå, Sweden), U. Nilsson (Umeå, Sweden), L. Hedman (Umeå, Sweden), C. Stridsman (Umeå, Sweden), H. Backman (Umeå, Sweden), A. Lindberg (Umeå, Sweden), A. Blomberg (Umeå, Sweden)
| |
Developing a claims’-based algorithm to identify US patients with COPD
S. Palli (Ridgefield, United States of America), S. Zhou (Wilmington, United States of America), A. Shaikh (Ridgefield, United States of America), V. Willey (Wilmington, United States of America)
| |
Characterization of the “frequent exacerbator phenotype” over a period of 3 years: Palomb cohort
E. Ouaalaya (Bordeaux, France), L. Falque (Bordeaux, France), J. Dupis (Pessac, France), M. Sabatini (Bayonne, France), A. Bernady (Cambo les bains, France), L. Nguyen (Bordeaux, France), A. Ozier (Bordeaux, France), C. Nocent-Ejnaini (Bayonne, France), F. Le Guillou (la Rochelle, France), M. Molimard (Bordeaux, France), C. Raherison-Semjen (Bordeaux, France)
| |
Time-updated resting heart rate better predictor for all-cause mortality in chronic obstructive pulmonary disease than baseline resting heart rate
A. Omlor (Homburg, Germany), F. Trudzinski (Homburg, Germany), M. Alqudrah (Homburg, Germany), F. Seiler (Homburg, Germany), F. Biertz (Hannover, Germany), C. Vogelmeier (Marburg, Germany), T. Welte (Hannover, Germany), H. Watz (Grosshansdorf, Germany), B. Waschki (Grosshansdorf, Germany), T. Brinker (Heidelberg, Germany), S. Fähndrich (Freiburg, Germany), R. Jörres (Munich, Germany), M. Böhm (Homburg, Germany), R. Bals (Homburg, Germany)
| |
Cognitive Function in COPD and controls
A. Gupta (Nottingham, United Kingdom), T. Mckeever (Nottingham, United Kingdom), N. Thompson (Nottingham, United Kingdom), C. Bolton (Nottingham, United Kingdom)
| |
Effects of Regular Use of ß2-Adrenergic Receptor Agonists on the Risk of Parkinson’s Disease in Patients with COPD
M. Etminan (Vancouver, Canada), A. Samii (Vancouver, Canada), M. Sadatsafavi (Vancouver, Canada), H. Tavakoli (Vancouver, Canada), W. Chen (Vancouver, Canada)
| |
Comparing the Comorbidity burden in Chronic Obstructive Pulmonary Disease and Heart Failure : evidence from a large population cohort
J. Carmona-Pírez (Zaragoza, Spain), A. Gimeno-Miguel (Zaragoza, Spain), B. Poblador-Plou (Zaragoza, Spain), J. Díez Manglano (Zaragoza, Spain), J. Marin Trigo (Zaragoza, Spain), B. Celli (Boston, United States of America), A. Prados-Torres (Zaragoza, Spain), M. Divo (Boston, United States of America)
| |
Late Breaking Abstract - Dietary patterns and lung function in a case-control study of asthma in Italian adults.
L. Chamitava (Verona, Italy), M. Zanolin (Verona, Italy), V. Garcia-Larsen (Baltimore, United States of America), M. Ferrari (Verona, Italy), I. Cerveri (Pavia, Italy), P. Pirina (Sassari, Italy), G. Verlato (Verona, Italy), L. Cazzoletti (Verona, Italy)
| |
Maternal blood pressure throughout pregnancy, gestational hypertension, and preeclampsia and offspring asthma
G. Zhang (Gothenburg, Sweden), M. Gissler (Helsinki, Finland), G. Devereux (Liverpool, United Kingdom), S. Shaheen (London, United Kingdom), H. Mcardle (Aberdeen, United Kingdom), A. Sheikh (Edinburgh, United Kingdom), B. Nwaru (Gothenburg, Sweden)
| |
Beta-blocker use is associated with lower mortality following myocardial infarction in patients with and without COPD. A Danish nationwide cohort study.
D. Rasmussen (Naestved, Denmark), U. Bodtger (Naestved, Denmark), M. Lamberts (Hellerup, Denmark), P. Lange (Copenhagen, Denmark), M. Jensen (Hellerup, Denmark)
| |
Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure
A. Tejeda Arturo (Mexico City, Mexico), L. Hernández Urquieta (Mexico City, Mexico), D. González Islas (Mexico City, Mexico), A. Flores Vargas (Mexico City, Mexico), A. Ibarra Fernández (Mexico City, Mexico), A. Jiménez Valentín (Mexico City, Mexico), R. Dávila Ramos (Mexico City, Mexico), A. Hernández López (Mexico City, Mexico), Y. Pilotzi Montiel (Mexico City, Mexico), R. Sánchez Santillán (Mexico City, Mexico)
| |